Suppressor of cytokine signaling 1 gene expression and polymorphisms in systemic lupus erythematosus

Abstract

With the aim of investigating the role of suppressor of cytokine signaling 1 (SOCS1) in the pathogenesis of systemic lupus erythematosus, 107 patients with systemic lupus erythematosus, 101 healthy controls, and 151 patients with ankylosing spondylitis were enrolled in this study. SOCS1 mRNA level was measured by the method of quantitative real-time polymerase chain reaction. SOCS1 polymorphisms were detected by the polymerase chain reaction/restriction fragment length polymorphisms method. Systemic lupus erythematosus disease activity was evaluated with the SLEDAI. This study showed that the SOCS1 mRNA expression was significantly higher in the patients with systemic lupus erythematosus than in the healthy controls (p = 0.0014). Patients with active systemic lupus erythematosus had a higher expression of SOCS1 mRNA than the patients with inactive systemic lupus erythematosus (p = 0.035). There was no significant difference in the frequencies of the SOCS1-1478CA/del polymorphisms among the patients with systemic lupus erythematosus, healthy controls, and patients with ankylosing spondylitis. The genotype frequency of the SOCS1-1478 polymorphisms in the dominant model (CA/del+del/del versus CA/CA) was significantly decreased in the patients with thrombocytopenia compared with those without thrombocytopenia (p_c = 0.035). Moreover, the allele frequency of SOCS1-1478del was also significantly lower in the patients with thrombocytopenia than in those without thrombocytopenia (p_c = 0.02). In conclusion, this study demonstrated that the expression of SOCS1 mRNA was significantly increased in patients with systemic lupus erythematosus. Moreover, SOCS1 mRNA levels in patients with active systemic lupus erythematosus were significantly higher than those in the inactive patients. We also found that the systemic lupus erythematosus patients with thrombocytopenia have a lower frequency of SOCS1-1478del compared with patients without thrombocytopenia. Lupus (2010) 19, 696—702.

Keywords

polymorphisms SOCS1 systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Sestak AL , Nath SK , Sawalha AH , Harley JB Current status of lupus genetics. Arthritis Res Ther 2007; 9: 210.

Jonsen A. , Bengtsson AA , Nived O. , Truedsson L. , Sturfelt G. Gene-environment interactions in the aetiology of systemic lupus erythematosus . Autoimmunity 2007; 40: 613-617.

Yoshimura A. , Nishinakamura H. , Matsumura Y. , Hanada T. Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res Ther 2005; 7: 100-110.

Kubo M. , Hanada T. , Yoshimura A. Suppressors of cytokine signaling and immunity. Nat Immunol 2003; 4: 1169-1176.

O’Shea JJ , Gadina M. , Schreiber RD Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002; 109(Suppl): S121-131.

Alexander WS Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002; 2: 410-416.

Nakagawa R. , Naka T. , Tsutsui H. , et al. SOCS-1 participates in negative regulation of LPS responses . Immunity 2002; 17: 677-687.

Kinjyo I. , Hanada T. , Inagaki-Ohara K. , et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 2002; 17: 583-591.

Tan EM , Cohen AS , Fries JF , et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.

10.

Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

11.

van der Linden S. , Valkenburg HA , Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-368.

12.

Radonic A. , Thulke S. , Mackay IM , Landt O. , Siegert W. , Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 2004; 313: 856-862.

13.

Harada M. , Nakashima K. , Hirota T. , et al. Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma. Am J Respir Cell Mol Biol 2007; 36: 491-496.

14.

Melzner I. , Bucur AJ , Bruderlein S. , et al. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 2005; 105: 2535-2542.

15.

Bombardier C. , Gladman DD , Urowitz MB , Caron D. , Chang CH Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.

16.

Fujimoto M. , Naka T. Regulation of cytokine signaling by SOCS family molecules. Trends Immunol 2003; 24: 659-666.

17.

Chong MM , Metcalf D. , Jamieson E. , Alexander WS , Kay TW Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation. Blood 2005; 106: 1668-1675.

18.

Naka T. , Matsumoto T. , Narazaki M. , et al. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc Natl Acad Sci U S A 1998; 95: 15577-15582.

19.

Starr R. , Metcalf D. , Elefanty AG , et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci U S A 1998; 95: 14395-14399.

20.

Fujimoto M. , Tsutsui H. , Xinshou O. , et al. Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int Immunol 2004; 16: 303-314.

21.

Hanada T. , Yoshida H. , Kato S. , et al. Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity 2003; 19: 437-450.

22.

Lahita RG The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999; 11: 352-356.

23.

Hooghe R. , Dogusan Z. , Martens N. , Velkeniers B. , Hooghe-Peters EL Effects of prolactin on signal transduction and gene expression: possible relevance for systemic lupus erythematosus. Lupus 2001; 10: 719-727.

24.

Tsao JT , Kuo CC , Lin SC The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients. Clin Exp Med 2008; 8: 179-185.